scPharmaceuticals Inc.
SCPHDelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001604950
scPharmaceuticals Inc. was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 7, 2025; 110 institutions reported holding it in 13F filings for Q3 2025, worth $232.3M in total; no superinvestor held it.
13F holders, Q4 2025
Institutional positions in scPharmaceuticals Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
SCPH is no longer listed, and 13F filings after Q3 2025 list far fewer holders. See Q3 2025
- Institutional holders
- 0
- −109 vs. Q3 2025
- Shares held
- 0
- −41.0M (−100.0%) vs. Q3 2025
- Total value
- $0
- −$232.2M (−100.0%) vs. Q3 2025
- New holders
- 0
- 0 more added
- Sold out
- 109
- 0 more reduced
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SCPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 110 | $232.3M |
| Q2 2025 | 98 | $145.7M |
| Q1 2025 | 88 | $98.7M |
| Q4 2024 | 86 | $140.8M |
| Q3 2024 | 95 | $169.8M |
| Q2 2024 | 77 | $121.0M |
| Q1 2024 | 76 | $134.2M |
| Q4 2023 | 81 | $175.4M |
| Q3 2023 | 73 | $213.1M |
| Q2 2023 | 81 | $290.8M |
| Q1 2023 | 63 | $223.2M |
| Q4 2022 | 59 | $153.5M |
| Q3 2022 | 40 | $91.3M |
| Q2 2022 | 38 | $75.9M |
| Q1 2022 | 37 | $90.1M |
| Q4 2021 | 33 | $80.0M |
| Q3 2021 | 31 | $107.9M |
| Q2 2021 | 38 | $97.9M |
| Q1 2021 | 46 | $114.1M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding scPharmaceuticals Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Atlantic Edge Private Wealth Management, LLC | 0 | $0 | 0.00% | −425−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −422−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −295−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −218−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −120−100.0% | Sold out |
| Sterling Capital Management LLC | 0 | $0 | 0.00% | −96−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −63−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Essential Partners LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | – | – | – | – | Not filed |